טוען...
The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus
Type 1 diabetes mellitus is a difficult disease to treat due to the relative paucity of therapeutic options other than injectable insulin. The latter, however, can induce hypoglycemia, which has been linked to enhanced cardiovascular risk. Sodium glucose cotransporter 2 (SGLT2) inhibitors are a new...
שמור ב:
| הוצא לאור ב: | Drugs |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6429906/ https://ncbi.nlm.nih.gov/pubmed/29663292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-018-0901-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|